Home > Annual Financials > ZENOTECH LABORATORIES

ZENOTECH LABORATORIES Financial Statement Analysis
[BOM: 532039]

The Revenues of ZENOTECH LABORATORIES have increased by 10,442.23% YoY .
The Earnings Per Share (EPS) of ZENOTECH LABORATORIES has decreased by Negative YoY.
COMMUNITY POLL
for ZENOTECH LABORATORIES
Please provide your vote to see the results

ZENOTECH LABORATORIES Last 5 Annual Financial Results
[BOM: 532039]

StandaloneMar2026
Mar2025
Mar2024
Mar2023
Mar2022
Revenues ₹4,305 Cr₹41 Cr₹42 Cr₹37 Cr₹22 Cr
Expenses ₹2,887 Cr₹24 Cr₹22 Cr₹19 Cr₹16 Cr
Operating Profit (Excl OI) ₹1,418 Cr₹17 Cr₹21 Cr₹17 Cr₹6.38 Cr
Other Income ₹155 Cr₹1.01 Cr₹1.08 Cr₹0.63 Cr₹0.41 Cr
Interest ₹0.00 Cr₹0.00 Cr₹0.11 Cr₹1.22 Cr₹1.55 Cr
Depreciation ₹696 Cr₹7.09 Cr₹7.17 Cr₹6.97 Cr₹6.46 Cr
Profit Before Tax ₹1,069 Cr₹11 Cr₹15 Cr₹9.90 Cr₹-1.22 Cr
Profit After Tax ₹561 Cr₹8.30 Cr₹12 Cr₹22 Cr₹-1.22 Cr
Earnings Per Share (Rs)₹-0.18₹0.92₹1.36₹1.90₹3.63
PAT Margin (%)-2.4613.0420.3227.3160.65
ROE(%)-1.126.019.6015.1537.26
ROCE(%)4.3811.4612.8918.3915.26
Total Debt/Equity(x)0.000.000.000.000.08

Key Financials

Market Cap : ₹ 268.4 Cr
Revenue (TTM) : ₹ 44.6 Cr
Net Profit(TTM) : ₹ -2.5 Cr
EPS (TTM) : ₹ -0.4
P/E (TTM) : -

Industry Peers & Returns1W1M1Y
ZENOTECH LABORATORIES -1.3% -5.8% -24.2%
SUN PHARMACEUTICAL INDUSTRIES -0.5% 0.8% 19%
DIVIS LABORATORIES 2.2% 23.1% 27.4%
TORRENT PHARMACEUTICALS -2.6% -1.6% 36%
CIPLA 0.8% 2.5% -3.7%
DR REDDYS LABORATORIES 2.6% -2.4% -5.6%
MANKIND PHARMA -1.1% -3.4% -7.2%
LUPIN -4.5% -8.8% 20.8%
ZYDUS LIFESCIENCES 6.2% 4.3% 16.8%


ZENOTECH LABORATORIES Revenues
[BOM: 532039]

Y-o-Y

10,442.23 %

5 Yr CAGR

272.14 %

Years Revenues % Change
Mar2026 ₹4,305 Cr
10,442.23
Mar2025 ₹41 Cr
-3.75
Mar2024 ₹42 Cr
16.02
Mar2023 ₹37 Cr
62.91
Mar2022 ₹22 Cr -


ZENOTECH LABORATORIES Operating Profit
[BOM: 532039]

Y-o-Y

8,136.16 %

5 Yr CAGR

286.11 %

Years Operating Profit % Change
Mar2026 ₹1,418 Cr
8,136.16
Mar2025 ₹17 Cr
-16.84
Mar2024 ₹21 Cr
18.57
Mar2023 ₹17 Cr
173.68
Mar2022 ₹6.38 Cr -

Operating Margins
Y-o-Y

-21.87 %

5 Yr CAGR

3.75 %

Years Operating Margin% % Change
Mar2026 32.94%
-21.87
Mar2025 42.16%
-13.61
Mar2024 48.8%
2.20
Mar2023 47.75%
67.96
Mar2022 28.43% -

ZENOTECH LABORATORIES Profit After Tax
[BOM: 532039]

Y-o-Y

6,663.34 %

5 Yr CAGR

Positive

Years Profit After Tax % Change
Mar2026 ₹561 Cr
6,663.34
Mar2025 ₹8.30 Cr
-28.36
Mar2024 ₹12 Cr
-47.76
Mar2023 ₹22 Cr
Positive
Mar2022 ₹-1.22 Cr -

PAT Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years PAT Margin(%) % Change
Mar2026 -2.46 %
Negative
Mar2025 13.04 %
-35.83
Mar2024 20.32 %
-25.60
Mar2023 27.31 %
-54.97
Mar2022 60.65 % -

ZENOTECH LABORATORIES Earnings Per Share (EPS)
[BOM: 532039]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years EPS % Change
Mar2026 ₹-0.18
Negative
Mar2025 ₹0.92
-32.35
Mar2024 ₹1.36
-28.42
Mar2023 ₹1.90
-47.66
Mar2022 ₹3.63 -

ZENOTECH LABORATORIES Return on Capital Employed (ROCE)
[BOM: 532039]

Y-o-Y

-61.78 %

5 Yr CAGR

-26.81 %

Years ROCE % Change
Mar2026 4.38%
-61.78
Mar2025 11.46%
-11.09
Mar2024 12.89%
-29.91
Mar2023 18.39%
20.51
Mar2022 15.26% -

ZENOTECH LABORATORIES Share Price vs Sensex

Current Share Price : ₹44.0
Current MarketCap: ₹ 268.4 Cr
Updated EOD on :Aug 11,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
ZENOTECH LABORATORIES

-1.3%

-5.8%

-24.2%

SENSEX

-0.4%

0.8%

-3%

ZENOTECH LABORATORIES related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about ZENOTECH LABORATORIES Financials


How the annual revenues of ZENOTECH LABORATORIES have changed ?

The Revenues of ZENOTECH LABORATORIES have increased by 10,442.23% YoY .

How the Earnings per Share (EPS) of ZENOTECH LABORATORIES have changed?

The Earnings Per Share (EPS) of ZENOTECH LABORATORIES has decreased by Negative YoY .